Many biologic drugs (e.g. therapeutics for cancer treatment like engineered antibodies with enhanced effector function, immunocytokines, T cell binders and immune checkpoint modulators) are intended to modulate the immune system and therefore may affect the cell-mediated immunity.
IBR Inc. has 20 years of expertise in cell-based assays. We leverage this knowhow to offer a variety of assays to assess cellular immunology in-vitro. The services of IBR Inc. include assay development and validation as well as measurement of samples under GxP. In combination with the immunogenicity testing service, IBR Inc. provides comprehensive solutions for your immunotoxicity evaluations.